
Quarterly ResultJul 23, 2026, 04:06 PM
AtriCure Q2 2026 Revenue $153.6M (+12.8%); Net Income $9.0M
AI Summary
AtriCure, Inc. announced strong financial results for the second quarter ended June 30, 2026. The company reported worldwide revenue of $153.6 million, marking a 12.8% increase year over year, and achieved a net income of $9.0 million, a significant improvement from a loss in the prior year. Adjusted EBITDA also saw substantial growth, rising 78% to $27.3 million. AtriCure provided optimistic full-year 2026 guidance, projecting revenue between $602 million and $610 million and adjusted EBITDA between $85 million and $89 million.
Key Highlights
- Worldwide revenue for Q2 2026 was $153.6 million, an increase of 12.8% year over year.
- Net income for Q2 2026 was $9.0 million, or $0.18 per diluted share.
- Adjusted EBITDA for Q2 2026 was $27.3 million, a 78% increase from Q2 2025.
- Gross margin for Q2 2026 was 77.2%, an increase of 269 basis points from Q2 2025.
- U.S. revenue increased 13.6% to $125.6 million in Q2 2026.
- International revenue increased 9.6% to $28.0 million in Q2 2026.
- Full-year 2026 revenue is projected to be approximately $602 million to $610 million.
- Full-year 2026 adjusted EBITDA is projected to be approximately $85 million to $89 million.
Price Impact
More from ATRC